China Jiangsu Delfu medical device Co.,Ltd latest company news about Reduced glycosylated hemoglobin, reduced mortality

Home News

Reduced glycosylated hemoglobin, reduced mortality

All Products

Insulin Pen (19)

Auto Injector Pen (17)

Smart Insulin Pen (6)

HGH Injection (6)

Somatropin Injection (5)

VEGF Injection (4)

Diabetes Insulin Pen‍ (6)

Prefilled Pen (5)

Electronic Syringe (6)

Continuous Glucose Monitor (2)

Blood Glucose Meter (3)

Insulin Pump (6)

Insulin Pen Needles (4)

Insulin Pen Cartridges (1)

Personal ECG Monitor (1)

Home ECG Monitor‍ (1)

Insulin Injection Pen (10)

Pharmaceutical Glass Packaging (17)

Home Care Electric Beds (0)

China Jiangsu Delfu medical device Co.,Ltd certification

I'm Online Chat Now

Company News

Reduced glycosylated hemoglobin, reduced mortality

Blood glucose is the key to the diagnosis of diabetes. For patients with type 2 diabetes, the treatment goal is to reduce the blood glucose level to an ideal range to reduce the incidence of chronic complications. Studies have shown that a few percent reduction in hba1c reduces the risk of death by about 20 percent, the risk of cardiovascular disease by about 15 percent, and even amputation or death from peripheral vascular disease by about 40 percent.

If hyperglycemia occurs but does not meet the diagnostic criteria, it is called pre-diabetes. At this time, lifestyle changes, exercise habits and diet control can be adopted to prevent the onset of diabetes. However, if the standard of treatment has been reached, the appropriate treatment should be selected according to the patient's situation, including the treatment of insulin.

Pub Time : 2019-01-10 08:46:02 >> News list

Contact Details

Jiangsu Delfu medical device Co.,Ltd

Contact Person: Mr. Hyman Chow

Tel: 0086-18168828053

Fax: 86-519-6882-8053